<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T15:39:45Z</responseDate>
  <request identifier="oai:figshare.com:article/32390247" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32390247</identifier>
        <datestamp>2026-09-14T07:02:05Z</datestamp>
        <setSpec>category_46</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_81</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Enhancing iNKT cell immunotherapy through the integration of optimized CAR endodomains and iNKT engagers</dc:title>
          <dc:creator>Kanagaraju Ponnusamy (20017025)</dc:creator>
          <dc:creator>Klesti Karaxhuku (23958382)</dc:creator>
          <dc:creator>Yuchao Jiang (23958376)</dc:creator>
          <dc:creator>Lyra Randzavola (23958388)</dc:creator>
          <dc:creator>Hongwei Ren (20015960)</dc:creator>
          <dc:creator>Ilia Leontari (20017067)</dc:creator>
          <dc:creator>Bryan Lye (20016244)</dc:creator>
          <dc:creator>Mehmood Zaidi (23958391)</dc:creator>
          <dc:creator>Edward J Bartlett (23958394)</dc:creator>
          <dc:creator>Edward W. Tate (7533255)</dc:creator>
          <dc:creator>Vasileios Pardalis (23958397)</dc:creator>
          <dc:creator>Dimitrios Leonardos (23958398)</dc:creator>
          <dc:creator>Reza Nadafi (23958401)</dc:creator>
          <dc:creator>Irene Sarkar (23958403)</dc:creator>
          <dc:creator>Rogier M Reijmers (23958406)</dc:creator>
          <dc:creator>Marco Bua (23958409)</dc:creator>
          <dc:creator>Maria Atta (23958412)</dc:creator>
          <dc:creator>Alexia Katsarou (23958415)</dc:creator>
          <dc:creator>Irene AG Roberts (20017163)</dc:creator>
          <dc:creator>Aristeidis Chaidos (23958416)</dc:creator>
          <dc:creator>Anastasios Karadimitris (20017208)</dc:creator>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>immunotherapy</dc:subject>
          <dc:subject>bispecific antibody</dc:subject>
          <dc:description>The study focused on optimising CAR iNKT platform for multiple myeloma in combination with bispecific engagers.</dc:description>
          <dc:date>2026-09-14T07:02:05Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.32390247.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Enhancing_iNKT_cell_immunotherapy_through_the_integration_of_optimized_CAR_endodomains_and_iNKT_engagers/32390247</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
